Template:Cardiac stimulants excluding cardiac glycosides: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
m 1 revision imported |
||
| (One intermediate revision by one other user not shown) | |||
| Line 13: | Line 13: | ||
| group1 = α | | group1 = α | ||
| list1 = | | list1 = | ||
* [[Denopamine]] | |||
* [[Metaraminol]] | * [[Metaraminol]] | ||
* [[Methoxamine]] | * [[Methoxamine]] | ||
* [[Midodrine]] | |||
* [[Norfenefrine]] | * [[Norfenefrine]] | ||
* [[Synephrine|Oxedrine]] | * [[Synephrine|Oxedrine]] | ||
* [[ | * [[Phenylephrine]] | ||
| group2 = β | | group2 = β | ||
| list2 = | | list2 = | ||
* [[Arbutamine]] | |||
* [[Dobutamine]] | * [[Dobutamine]] | ||
* [[Isoprenaline]] | * [[Isoprenaline]] | ||
* [[Prenalterol]] | * [[Prenalterol]] | ||
| Line 33: | Line 33: | ||
* [[Droxidopa]] | * [[Droxidopa]] | ||
* [[Epinephrine]] # | * [[Epinephrine]] # | ||
* [[Etilefrine]] | |||
* [[Norepinephrine (medication)|Norepinephrine]] | * [[Norepinephrine (medication)|Norepinephrine]] | ||
}} | }} | ||
| Line 44: | Line 44: | ||
| group3 = Both | | group3 = Both | ||
| list3 = | | list3 = | ||
* [[Docarpamine]] | |||
* [[Dopamine]] # | * [[Dopamine]] # | ||
* [[Dopexamine]] | * [[Dopexamine]] | ||
| Line 51: | Line 52: | ||
| group4 = Unknown/ungrouped | | group4 = Unknown/ungrouped | ||
| list4 = | | list4 = | ||
* [[Cafedrine]] | |||
* [[Dimetofrine]] | * [[Dimetofrine]] | ||
* [[Gepefrine]] | * [[Gepefrine]] | ||
* [[ | * [[Mephentermine]] | ||
* [[Theodrenaline]] | * [[Theodrenaline]] | ||
| Line 61: | Line 63: | ||
| list2 = | | list2 = | ||
* [[Amrinone]] | * [[Amrinone]] | ||
* [[Bucladesine]] | |||
* [[Enoximone]] | |||
* [[Milrinone]] | * [[Milrinone]] | ||
* [[ | * [[Vesnarinone]] | ||
| group3 = Other cardiac stimulants | | group3 = Other cardiac stimulants | ||
| list3 = | | list3 = | ||
* [[Angiotensinamide]] | * [[Angiotensinamide]] | ||
* [[Levosimendan]] | * [[Levosimendan]] | ||
* [[Omecamtiv mecarbil]] | |||
* [[Pimobendan]] | * [[Pimobendan]] | ||
* [[Xamoterol]] | |||
| belowstyle = | | belowstyle = padding: 0px; | ||
| below = {{PharmNavFootnote}} | | below = {{PharmNavFootnote}} | ||
| Line 80: | Line 84: | ||
[[Category:Drug_templates by ATC]] | [[Category:Drug_templates by ATC]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 18:15, 8 March 2025
| Cardiac stimulants excluding cardiac glycosides (C01C) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
